Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -55.85% is in line with its 5-year average of -59.39%, around the middle of its 5-year range (-83.65%–-39.84%).
As of the fiscal period ended Sunday, May 31, 2026. 19.93% above its 12-month average of -69.75%.
Reported quarterly return on assets; no daily interpolation. Q4 FY2026 (2026-05-31): -16.94%.
RETURN ON ASSETS (ROA)
-55.85%
RETURN ON ASSETS (ROA) AVG TTM
-69.75%
RETURN ON ASSETS (ROA) AVG 3Y
-63.38%
RETURN ON ASSETS (ROA) AVG 5Y
-59.39%
RETURN ON ASSETS (ROA) AVG 10Y
-44.35%
RETURN ON ASSETS (ROA) AVG 15Y
-29.70%
RETURN ON ASSETS (ROA) AVG 20Y
-19.78%
CURRENT VS TTM AVG
+19.93%
CURRENT VS 3Y AVG
+11.87%
CURRENT VS 5Y AVG
+5.96%
CURRENT VS 10Y AVG
-25.92%
CURRENT VS 15Y AVG
-88.05%
CURRENT VS 20Y AVG
-182.39%
SECTOR MEDIAN · HEALTHCARE
-26.90%
median of 504 covered companies
CURRENT VS SECTOR MEDIAN
-107.62%
vs the sector median at left
Biomerica, Inc.
Market Cap
$6.46M
Return on Assets (ROA)
-55.85%
TTM Avg
-69.75%
3Y Avg
-63.38%
5Y Avg
-59.39%
Market Cap
$6.41M
Return on Assets (ROA)
-426.88%
TTM Avg
-139.62%
3Y Avg
-270.47%
5Y Avg
-207.15%
Market Cap
$6.25M
Return on Assets (ROA)
-99.97%
TTM Avg
-120.54%
3Y Avg
-89.96%
5Y Avg
-79.52%
Market Cap
$6.10M
Return on Assets (ROA)
-81.62%
TTM Avg
-81.33%
3Y Avg
-106.24%
5Y Avg
-102.80%
Market Cap
$6.29M
Return on Assets (ROA)
83.82%
TTM Avg
-0.56%
3Y Avg
-31.49%
5Y Avg
-28.41%
Market Cap
$6.19M
Return on Assets (ROA)
-54.95%
TTM Avg
-72.19%
3Y Avg
-72.80%
5Y Avg
-69.14%
Market Cap
$6.72M
Return on Assets (ROA)
-71.23%
TTM Avg
-61.08%
3Y Avg
-51.04%
5Y Avg
-61.11%
Market Cap
$6.80M
Return on Assets (ROA)
-50.98%
TTM Avg
-191.11%
3Y Avg
-206.10%
5Y Avg
-240.87%
Market Cap
$6.85M
Return on Assets (ROA)
-97.60%
TTM Avg
-274.34%
3Y Avg
-160.93%
5Y Avg
-165.76%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Biomerica, Inc. (BMRA) | $6.46M | -55.85% | -69.75% | -63.38% | -59.39% |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.41M | -426.88% | -139.62% | -270.47% | -207.15% |
| Femasys Inc. (FEMY)vs › | $6.25M | -99.97% | -120.54% | -89.96% | -79.52% |
| Cardio Diagnostics Holdings, Inc. (CDIO)vs › | $6.10M | -81.62% | -81.33% | -106.24% | -102.80% |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $6.29M | 83.82% | -0.56% | -31.49% | -28.41% |
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs › | $6.19M | -54.95% | -72.19% | -72.80% | -69.14% |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.72M | -71.23% | -61.08% | -51.04% | -61.11% |
| Aclarion, Inc. (ACON)vs › | $6.80M | -50.98% | -191.11% | -206.10% | -240.87% |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.85M | -97.60% | -274.34% | -160.93% | -165.76% |
| Co-Diagnostics, Inc. (CODX)vs › | $7.00M | -283.63% | -124.17% | -74.25% | -35.74% |
ROA
-55.9%
ROE
-143.5%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2026-05-31 | -55.85% |
| 2025-05-31 | -83.65% |
| 2024-05-31 | -64.60% |
| 2023-05-31 | -49.40% |
| 2022-05-31 | -39.84% |
| 2021-05-31 | -63.00% |
| 2020-05-31 | -13.55% |
| 2019-05-31 | -45.62% |
| 2018-05-31 | -28.07% |
| 2017-05-31 | -18.11% |
| 2016-05-31 | -26.19% |
| 2015-05-31 | -5.41% |
| 2014-05-31 | -3.33% |
| 2013-05-31 | 8.40% |
| 2012-05-31 | 9.84% |
| 2011-05-31 | 3.18% |
| 2010-05-31 | -6.61% |
| 2009-05-31 | 6.87% |
| 2008-05-31 | 33.48% |
| 2007-05-31 | 16.65% |
| 2006-05-31 | 9.48% |
| 2005-05-31 | 2.80% |
| 2004-05-31 | -4.01% |
| 2003-05-31 | -4.04% |
| 2002-05-31 | -7.97% |
| 2001-05-31 | -49.98% |
| 2000-05-31 | -57.77% |
| 1999-05-31 | -1.28% |
| 1998-05-31 | 1.33% |
| 1997-05-31 | 5.41% |
